On September 24, 2018 Bausch Health Companies Inc. (NYSE/TSX: BHC) reported that the company will participate in two investor conferences in October (Press release, Valeant, SEP 24, 2018, View Source [SID1234529771]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Joseph C. Papa, chairman and chief executive officer, and Sam Eldessouky, senior vice president and corporate controller, are scheduled to participate at the Cantor Fitzgerald Global Healthcare Conference in New York on Oct. 1, 2018 at 3:30 p.m. EDT.

Paul S. Herendeen, executive vice president and chief financial officer, William Woodfield, vice president and treasurer, and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the Deutsche Bank 26th Annual Leveraged Finance Conference in Scottsdale, Ariz. on Oct. 2, 2018 at 10:40 a.m. MST (1:40 p.m. EDT).

Live webcasts and audio archives of the events will be available on the Investor Relations page of the Bausch Health Companies Inc. web site at: View Source